NCT00364702

Brief Summary

Using a virtual reality program in screening and treatment of ADHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Aug 2006

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 16, 2006

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
Last Updated

August 17, 2011

Status Verified

July 1, 2006

Enrollment Period

11 months

First QC Date

August 15, 2006

Last Update Submit

August 16, 2011

Conditions

ADHD

Keywords

Virtual RealityADHDMethylphenidate

Outcome Measures

Primary Outcomes (1)

  • Virtual Reality program test results

Interventions

methylphenidateDRUG

Eligibility Criteria

Age10 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ\>80

You may not qualify if:

  • ABNORMAL NEUROLOGICAL STATUS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaari Zedek Pediatric Neurology Unit

Jerusalem, 91031, Israel

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Methylphenidate

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • V. Gross, Prof/ md

    Shaari Zedek Pediatric Neurology Unit

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 15, 2006

First Posted

August 16, 2006

Study Start

August 1, 2006

Primary Completion

July 1, 2007

Study Completion

July 1, 2007

Last Updated

August 17, 2011

Record last verified: 2006-07

Locations

IL(1)